162 related articles for article (PubMed ID: 9421476)
1. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.
Jong MC; Gijbels MJ; Dahlmans VE; Gorp PJ; Koopman SJ; Ponec M; Hofker MH; Havekes LM
J Clin Invest; 1998 Jan; 101(1):145-52. PubMed ID: 9421476
[TBL] [Abstract][Full Text] [Related]
2. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
[TBL] [Abstract][Full Text] [Related]
3. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance.
Muurling M; van den Hoek AM; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ
J Lipid Res; 2004 Jan; 45(1):9-16. PubMed ID: 14523051
[TBL] [Abstract][Full Text] [Related]
5. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
[TBL] [Abstract][Full Text] [Related]
6. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
[TBL] [Abstract][Full Text] [Related]
7. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
[TBL] [Abstract][Full Text] [Related]
9. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1.
Jong MC; Voshol PJ; Muurling M; Dahlmans VE; Romijn JA; Pijl H; Havekes LM
Diabetes; 2001 Dec; 50(12):2779-85. PubMed ID: 11723061
[TBL] [Abstract][Full Text] [Related]
10. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice.
van Ree JH; Hofker MH; van den Broek WJ; van Deursen JM; van der Boom H; Frants RR; Wieringa B; Havekes LM
Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):905-11. PubMed ID: 7848292
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
[TBL] [Abstract][Full Text] [Related]
12. Effects of fenofibrate on hyperlipidemia and postprandial triglyceride metabolism in human apolipoprotein C1 transgenic mice.
Jong MC; Dahlmans VE; Princen HM; Hofker MH; Havekes LM
Atherosclerosis; 1998 Dec; 141 Suppl 1():S77-80. PubMed ID: 9888647
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.
Westerterp M; Van Eck M; de Haan W; Offerman EH; Van Berkel TJ; Havekes LM; Rensen PC
Atherosclerosis; 2007 Nov; 195(1):e9-16. PubMed ID: 17320883
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members.
van Ree JH; van den Broek WJ; van der Zee A; Dahlmans VE; Wieringa B; Frants RR; Havekes LM; Hofker MH
Hum Mol Genet; 1995 Aug; 4(8):1403-9. PubMed ID: 7581381
[TBL] [Abstract][Full Text] [Related]
15. Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration, but not visceral fat, in patients with type 2 diabetes.
Bouillet B; Gautier T; Aho LS; Duvillard L; Petit JM; Lagrost L; Vergès B
Diabetes Metab; 2016 Sep; 42(4):263-6. PubMed ID: 26934823
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification.
Westerterp M; Berbée JF; Delsing DJ; Jong MC; Gijbels MJ; Dahlmans VE; Offerman EH; Romijn JA; Havekes LM; Rensen PC
J Lipid Res; 2007 Jun; 48(6):1353-61. PubMed ID: 17339654
[TBL] [Abstract][Full Text] [Related]
17. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.
Shachter NS; Ebara T; Ramakrishnan R; Steiner G; Breslow JL; Ginsberg HN; Smith JD
J Clin Invest; 1996 Aug; 98(3):846-55. PubMed ID: 8698877
[TBL] [Abstract][Full Text] [Related]
18. Development of atopic dermatitis in mice transgenic for human apolipoprotein C1.
Nagelkerken L; Verzaal P; Lagerweij T; Persoon-Deen C; Berbee JF; Prens EP; Havekes LM; Oranje AP
J Invest Dermatol; 2008 May; 128(5):1165-72. PubMed ID: 18049452
[TBL] [Abstract][Full Text] [Related]
19. Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids.
Araki S; Okazaki M; Goto S
Gerontology; 2004; 50(4):206-15. PubMed ID: 15258425
[TBL] [Abstract][Full Text] [Related]
20. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.
Jong MC; Hofker MH; Havekes LM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):472-84. PubMed ID: 10073946
[No Abstract] [Full Text] [Related]
[Next] [New Search]
